title: Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophy.
authors.forename: J A
authors.initials: JA
authors.lastname: Walker-Smith
authors.forename: A D
authors.initials: AD
authors.lastname: Phillips
authors.forename: N
authors.initials: N
authors.lastname: Walford
authors.forename: H
authors.initials: H
authors.lastname: Gregory
authors.forename: J D
authors.initials: JD
authors.lastname: Fitzgerald
authors.forename: K
authors.initials: K
authors.lastname: MacCullagh
authors.forename: N A
authors.initials: NA
authors.lastname: Wright
mesh_terms: D001284:Atrophy; D003967:Diarrhea / Q000151:congenital / Q000188:drug therapy / Q000473:pathology; D004815:Epidermal Growth Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D007413:Intestinal Mucosa / Q000473:pathology*; D008871:Microvilli / Q000473:pathology; D010446:Peptide Fragments / Q000008:administration & dosage / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D013577:Syndrome
chemical_list: D010446:Peptide Fragments; D011994:Recombinant Proteins; D004815:Epidermal Growth Factor; C035693:epidermal growth factor (1-45)